McPeak Paula R
Radiol Technol. 2014 May-Jun;85(5):523M-538M; quiz 539M-541M.
Breast cancer is the most common cancer in women, but with early detection, it is a treatable disease. Mammography has long been the medical imaging standard for breast cancer screening, with other breast imaging modalities used as adjunct procedures to support diagnostic interpretation. Molecular breast imaging (MBI) was introduced in the past decade as a promising adjunct to mammography. Using a radiopharmaceutical and a dedicated imaging device, MBI technology helps physicians examine metabolic activity within the breast. This article provides a review of breast anatomy and composition, explores genetic factors related to breast cancer, and examines practice guidelines related to MBI.
乳腺癌是女性中最常见的癌症，但如果能早期发现，它是一种可治疗的疾病。长期以来，乳房X线摄影一直是乳腺癌筛查的医学成像标准，其他乳房成像方式则用作辅助程序以支持诊断解读。分子乳腺成像（MBI）在过去十年中作为乳房X线摄影的一种有前景的辅助手段被引入。MBI技术使用一种放射性药物和一台专用成像设备，帮助医生检查乳房内的代谢活动。本文回顾了乳房的解剖结构和组成，探讨了与乳腺癌相关的遗传因素，并研究了与MBI相关的实践指南。
